Skip to main content

Ventas Value Stock - Dividend - Research Selection

Ventas

ISIN: US92276F1003 , WKN: 878380

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. References to ?Ventas? or the ?Company? mean Ventas, Inc. and its consolidated subsidiaries unless otherwise expressly noted. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Ventas Q4 Earnings Call Highlights

2026-02-07
Ventas (NYSE:VTR) executives told investors the company delivered what CEO Deborah A. Cafaro described as an “outstanding year” in 2025, driven primarily by senior housing momentum under the company’s “1, 2, 3 strategy” focused on senior housing organic growth, value-creating investments, and portfo

Ventas Inc (VTR) Q4 2025 Earnings Call Highlights: Strong Growth and Strategic Investments ...

2026-02-06
Ventas Inc (VTR) reports robust financial results with a 9% increase in normalized FFO per share and significant senior housing investments, while navigating market challenges.

Ventas Q4 FFO Meet, Revenues Beat Estimates, Same-Store Cash NOI Rises

2026-02-06
VTR posts strong Q4 FFO results with higher FFO and revenues, fueled by gains in SHOP and OM&R offsetting a dip in triple-net results.

Ventas, Inc. (VTR) Q4 2025 Earnings Call Transcript

2026-02-06

NAV Monitor: U.S. REITs End January At Median 16.2% Discount To Net Asset Value

2026-02-06
Publicly listed US equity REITs with market capitalizations of at least $200M closed January trading at a median 16.2% discount to consensus estimates for NAV per share. Read more here.

Ventas (VTR) Reports Q4 Earnings: What Key Metrics Have to Say

2026-02-05
Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Ventas (VTR) Matches Q4 FFO Estimates

2026-02-05
Ventas (VTR) delivered FFO and revenue surprises of +0.38% and +4.68%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Ventas: Q4 Earnings Snapshot

2026-02-05
The Chicago-based real estate investment trust said it had funds from operations of $427.1 million, or 89 cents per share, in the period. The average estimate of five analysts surveyed by Zacks Investment Research was for funds from operations of 89 cents per share. Funds from operations is a closely watched measure in the REIT industry.

Ventas Reports Fourth Quarter and Full Year 2025 Results, Provides 2026 Outlook and Increases Dividend

2026-02-05
CHICAGO, February 05, 2026--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today reported results for the full year and fourth quarter ended December 31, 2025.

Clarion Partners Strengthens Growing Healthcare Real Estate Practice with the Addition of Two Senior Investment Professionals

2026-02-05
NEW YORK, February 05, 2026--Clarion Partners, LLC ("Clarion"), a leading U.S. commercial real estate investment firm, today announced the appointment of two new senior team members to accommodate the expansion of the Firm’s existing Healthcare real estate business. Clarion’s growing $3 billion Healthcare platform, which currently has ~$600M in additional transactions underway, focuses on investments in senior housing, medical office, inpatient rehabilitation, and related assets across the risk